Acute Intestinal Infections in Children Vaccinated against Rotavirus Infection
https://doi.org/10.22627/2072-8107-2026-25-2-13-16
Abstract
In Russia, viral agents dominate the etiological structure of аcute intestinal infections (AII), with rotavirus and norovirus playing the major role. Vaccination against rotavirus infection (RVI) demonstrates high efficacy (78—94%) in preventing severe forms requiring hospitalization. The introduction of rotavirus vaccination has altered the etiological landscape; however, the clinical features of AII in vaccinated children, including breakthrough infections and coinfections, remain insufficiently studied.
Objective: to analyze the course of acute intestinal infections (AII) in unvaccinated and rotavirus-vaccinated children aged 8 months to 3 years.
Materials and methods. A prospective observational cohort study was conducted at the G.N. Speransky Children's City Clinical Hospital (Moscow) in 2023—2024. The study included 205 patients hospitalized with AII within the first three days of symptom onset. Two groups were formed: children vaccinated against RVI (n = 93) and unvaccinated children (n = 112). Etiological diagnosis was performed by PCR; rotavirus genotyping was carried out (Sanger sequencing). Statistical analysis included the Mann—Whitney U test, Pearson's chi-squared test, calculation of odds ratios (OR) and 95% confidence intervals (CI).
Results. The groups were comparable in sex, age, and time of hospitalization (median — second day of illness). Vaccinated patients had a significantly shorter duration of illness: median 5 days [4;5] versus a longer course in the unvaccinated group (p = 0.033). The frequency of gastroenteritis in the vaccinated group was almost twofold lower — 29.0% (95% CI: 20.4—38.6%) compared to 56.6% (95% CI: 46.7—65.3%) in the comparison group (p = 0.001). Rotavirus was detected significantly less often in vaccinated children: 10/93 (10.8%) versus 41/109 (37.6%) in unvaccinated children (χ² = 17.79; p < 0.0001; OR = 0.200; 95% CI: 0.093—0.428). The detection rate of norovirus did not differ between the groups (30.1% vs 20.2%; p = 0.143). Campylobacter was detected more frequently in vaccinated children: 12/93 (12.9%) versus 4/109 (3.7%) (p = 0.031; OR = 3.89; 95% CI: 1.21—12.51); however, the authors note the possibility of Berkson's bias due to the small number of cases. Among vaccinated children with confirmed rotavirus infection (n = 10), hyperthermia above 39°C was not recorded (0%), whereas in the unvaccinated group (n = 42) this symptom was observed in 31% (95% CI: 16.7—45.0%). The predominant rotavirus genotype in both groups was G3[P8].
About the Authors
E. S. BukhantsovaRussian Federation
Moscow
I. I. Afukov
Russian Federation
Moscow
O. В. Kovalev
Russian Federation
Moscow
O. V. Molochkova
Russian Federation
Moscow
O. V. Shamsheva
Russian Federation
Moscow
A. D. Takhtarova
Russian Federation
Moscow
N. O. Sevryukov
Russian Federation
Moscow
A. A. Trushina
Russian Federation
Moscow
I. A. Litvinenko
Russian Federation
Moscow
I. B. Kamenskaya
Russian Federation
Moscow
K. R. Popova
Russian Federation
Moscow
Y. I. Kyrlan
Russian Federation
Moscow
O. S. Ivaniuk
Russian Federation
Moscow
M. A. Gordukova
Russian Federation
Moscow
A. B. Durdina
Russian Federation
Moscow
References
1. GBD 2021 Diarrhoeal Diseases Collaborators. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990—2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis. 2025 May;25(5):519—536. doi: 10.1016/S1473-3099(24)00691-1
2. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2024: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare; 2025. 424 p. (In Russ).
3. Diallo AO, Wikswo ME, Sulemana I, Sahni LC, Boom JA, et al. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009—2022. Pediatrics. 2024 Oct 1;154(4):e2024066879. doi: 10.1542/peds.2024-066879
4. Pérez-Ortín R, Santiso-Bellón C, Vila-Vicent S, Carmona-Vicente N, Rodríguez-Díaz J, Buesa J. Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain. BMC Infect Dis. 2019 Nov 27;19(1):998. doi: 10.1186/s12879-019-4550-x
5. Simsek C, Bloemen M, Jansen D, Beller L, Descheemaeker P, Reynders M, Van Ranst M, Matthijnssens J. High Prevalence of Coinfecting Enteropathogens in Suspected Rotavirus Vaccine Breakthrough Cases. J Clin Microbiol. 2021 Nov 18;59(12):e0123621. doi: 10.1128/JCM.01236-21
6. Halasa N, Piya B, Stewart LS, Rahman H, Payne DC, et al. The Changing Landscape of Pediatric Viral Enteropathogens in the Post-Rotavirus Vaccine Era. Clin Infect Dis. 2021 Feb 16;72(4):576—585. doi: 10.1093/cid/ciaa100
7. Lin FJ, Huang YC, Huang YC, Huang LM, Liu CC, et al. Clinical and epidemiological features in hospitalized young children with acute gastroenteritis in Taiwan: A multicentered surveillance through 2014—2017. J Formos Med Assoc. 2022 Feb;121(2):519—528. doi: 10.1016/j.jfma.2021.06.001
8. Harrison CJ, Hassan F, Lee B, Boom J, Sahni LC, Johnson C, Dunn J, Payne DC, Wikswo ME, Parashar U, Selvarangan R. Multiplex PCR Pathogen Detection in Acute Gastroenteritis Among Hospitalized US Children Compared With Healthy Controls During 2011—2016 in the Post-Rotavirus Vaccine Era. Open Forum Infect Dis. 2021 Nov 24;8(12):ofab592. doi: 10.1093/ofid/ofab592
9. Mason J, Iturriza-Gomara M, O'Brien SJ, Ngwira BM, Dove W, Maiden MC, Cunliffe NA. Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus co-infections. PLoS One. 2013;8(3):e59663. doi: 10.1371/journal.pone.0059663
10. Rönnelid Y, Bonkoungou IJO, Ouedraogo N, Barro N, Svensson L, Nordgren J. Norovirus and rotavirus in children hospitalised with diarrhoea after rotavirus vaccine introduction in Burkina Faso. Epidemiol Infect. 2020 Oct 1;148:e245. doi: 10.1017/S0950268820002320
11. Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, et al. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2022 Jan 1;149(1):e2020049884. doi: 10.1542/peds.2020-049884
12. Ciszewski J, Taniuchi M, Lee B, Colgate ER, Platts-Mills JA,et al. Differences in Rotavirus Shedding and Duration by Infant Oral Rotavirus Vaccination Status in Dhaka, Bangladesh, 2011—2014. J Infect Dis. 2024 Jul 25;230(1):e75—e79. doi: 10.1093/infdis/jiad502
13. Girina AA, Petrovsky FI, Sosyskina NV, Zaplatnikov AL. Assessment of the incidence of rotavirus infection and the effectiveness of vaccination prophylaxis in the Khanty-Mansiysk Autonomous Okrug Yugra in 2014—2018. Epidemiology and Vaccinal Prevention. 2020;19(2):95—101. doi: 10.31631/2073-3046-2020-19-2-95-101 (In Russ).
Review
For citations:
Bukhantsova E.S., Afukov I.I., Kovalev O.В., Molochkova O.V., Shamsheva O.V., Takhtarova A.D., Sevryukov N.O., Trushina A.A., Litvinenko I.A., Kamenskaya I.B., Popova K.R., Kyrlan Y.I., Ivaniuk O.S., Gordukova M.A., Durdina A.B. Acute Intestinal Infections in Children Vaccinated against Rotavirus Infection. CHILDREN INFECTIONS. 2026;25(2):13-16. (In Russ.) https://doi.org/10.22627/2072-8107-2026-25-2-13-16
JATS XML




































